美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      If you know anything about Charles Barkley, you know he likes to talk a big game. However, when it comes to GLP-1 drugs, the NBA Hall of Famer opts to walk the walk.

      He candidly walked consumers through his GLP-1 journey, which started with Eli Lilly’s type 2 diabetes drug Mounjaro. Following shortages of tirzepatide, he joined forces with telehealth platform Ro to raise awareness about taking branded GLP-1 agonists.

      Using those two drugs, he lost more than 100 pounds. Now, he’s resumed his weight-loss journey thanks to Lilly’s obesity drug Zepbound.

      Through this partnership, Barkley has appeared in a series of ads highlighting challenges patients face as they attempt to access GLP-1 medications.

      Ro is also collaborating with Barkley’s recently launched Round Mound Media on projects focused on obesity education and raising awareness of the efficacy of these treatments. 

      Return to Healthcare Marketing Influencers.